MedTrace Logo

Efficacy of Omega-3/Omega-6 Fatty Acids in Pre-school Children at Risk for ADHD

NCT01795040 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 40

Last updated 2017-03-16

No results posted yet for this study

Summary

The efficacy of PUFAs (as nutritional supplement) in/for pre-school children with ADHS symptoms will be evaluated in a randomised controlled doubleblind trail with children aged 3-6 years.

Conditions

  • Children With ADHD Symptoms >90th Percentile (FBB-ADHS-V); no Beginning or Completion of Psychotherapeutically or Psychopharmalogical Treatment During the Study

Interventions

DIETARY_SUPPLEMENT

omega-3/omega-6 fatty acids (PUFAs)

Equazen 500mg/day= 116 mg docosahexaenoic acid, 372 mg Eicosapentaenoic acid, 40 mg gamma-Linolenic acid

Sponsors & Collaborators

  • University of Cologne

    lead OTHER

Principal Investigators

  • Manfred Doepfner, Prof. Dr. · Department of Child and Adolescent Psychiatry Univ. Cologne

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
CROSSOVER

Eligibility

Min Age
3 Years
Max Age
6 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2010-09-30
Primary Completion
2017-04-30
Completion
2017-05-31

Countries

  • Germany

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01795040 on ClinicalTrials.gov